Erythema gyratum repens responding to cetirizine hydrochloride

Journal of Dermatology

Volumn 29, Issue 11, 2002, Pages 731-734

  Miyagawa, Fumi ^a   Danno, Kiichiro ^a   Uehara, Masami ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Cetirizine; Erythema gyratum repens; Pancreatic cancer

Indexed keywords

BETAMETHASONE; CETIRIZINE; CORTICOSTEROID; OXATOMIDE;

ADULT; ARTICLE; CASE REPORT; CELL INFILTRATION; CELL VACUOLE; EOSINOPHILIA; ERYTHEMA; ERYTHEMA GYRATUM REPENS; HISTOPATHOLOGY; HUMAN; KERATOSIS PALMOPLANTARIS; LIVER METASTASIS; MALE; PANCREAS CANCER; PRURITUS; SKIN BIOPSY; TREATMENT OUTCOME;

EID: 0036859117     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2002.tb00211.x     Document Type: Article

References (17)

1. Gammel JA: Erythema Gyratum Repens, Arch Derm Syph, 66: 494-505, 1953.
2. Boyd AS, Neldner KH, Menter A: Erythema gyratum repens: A paraneoplastic eruption, J Am Acad Dermatol, 26: 757-762, 1992.
3. Levine LE, Morgan NE, Fretzin D, Rubenstein D: Erythema gyratum repens, Arch Dermatol, 121: 170-171, 1985.
4. Toussaint S, Kamino H: Noninfectious erythematous, papular, and squamous diseases, in Elder D, Elenitsas R, Jaworsky C, Johnson B (eds): Lever's Histopathology of the Skin, 8th Ed, Lippincott-Raven Publishers, Philadelphia, 1997, p 154.
5. Leavell UW, Winternitz WW, Black JH: Erythema gyratum repens and undifferentiated carcinoma, Arch Dermatol, 95: 69-72, 1967.
6. Van Dijk E: Erythema gyratum repens, Dermatologica, 123: 301-310, 1961.
7. Holt PJA, Davies MG: Erythema gyratum repens-An immunologically mediated dermatosis?, Br J Dermatol, 96: 343-347, 1977.
8. Albers SE, Fenske NA, Glass LF: Erythema gyraturn repens: Direct immunofluorescence microscopic findings, J Am Acad Dermatol, 29: 493-494, 1993.
9. Garrett SJ, Roenigk HH: Erythema gyratum repens in a healthy woman, J Am Acad Dermatol, 26: 121-122, 1992.
10. Caux F, Lebbe C, Thomine E, et al: Erythema gyratum repens. A case studied with immunofluorescence, immunoelectron microscopy and immunohistochemistry, Br J Dermatol, 131: 102-107, 1994.
11. Stone OJ: A mechanism of peripheral spread or localization of inflammatory reactions-Role of the localized ground substance adaptive phenomenon, Med Hypotheses, 29: 167-169, 1989.
12. Charlesworth EN, Kagay-Sobotka A, Norman PS, Lichtenstein LM: Effect of cetirizine on mast cell-mediator release and cellular traffic during cutaneous late-phase reaction, J Allergy Clin Immunol, 83: 905-912, 1989.
13. Fadel R, Herpin-Richard N, Rihoux JP, Henocq E: Inhibitory effect of cetirizine 2HCl on eosinophil magration in vivo. Clin Allergy, 17: 373-379, 1987.
14. Zuberbier T, Aberer W, Burtin B, et al: Efficacy of cetirizine in cholinergic urticaria, Acta Derm Venereol (Stockh), 75: 147-149, 1995.
15. Zuberbier T, Munzberger Ch, Haustein U, et al: Double-blind crossover study of high-dose cetirizine in cholinergic urticaria, Dermatology, 193: 324-327, 1996.
16. Pevny I: Erythema gyratum repens, Z Haut Geschlechtskr, 40: 260-270, 1966.
17. Skolnick M: Erythema gyratum repens with metastatic adenocarcinoma, Arch Dermatol, 111: 227-229, 1975.